Surviving Spouses And The Children of Those Who Have Died From Cancer Are Filing Zantac Cancer Lawsuits

Sanofi earned billions of dollars in profits from selling the leading heartburn and acid reflux medicine.

Tuesday, November 10, 2020 - No one is disputing that elevated levels of NDMA in Zantac tablets, nor that NDMA causes cancer. Hundreds of individual lawsuits allege taking the popular antacid regularly and for more than a year caused them to develop stomach, liver, kidney, colon, prostate, bladder, and many other types of cancer of the digestive system. Zantac lawsuits are not limited to those who are suffering from cancer but also include lawsuits filed by the surviving loved ones of those who died from cancer allegedly as a result.

Online chat room conversations are full of people complaining that their spouse died. About Lawsuits.com published a comment from a woman named Janice on October 30, 2019, "My husband passed away 10-27-2019 from pancreatic cancer. Took Zantac for years for heartburn and acid reflux." Josephine wrote back a year ago on December 10, 2019. "My husband Lennie Clark died May the 20 with Liver Cancer and pancreatic cancer he did take over counter Zantac." Robert wrote, "my husband had a nephrectomy, later it has been found in his lungs and (lymph nodes) with stage 4 cancer after taking both Nexium and Zantac." Robin complained of "losing her husband at age 62 in 2011 to esophageal cancer. Being an OTR truck driver and eating in truck stops he took Zantac like eating M & M's." The survivors of those who have died from Zantac cancer also note that they have no history of cancer in their family. Martha said her husband died of pancreatic cancer in Dec 2019 at age 73, "and been taking Zantac or Ranitidine for years. His family and doctors were mystified as to the cancer origin as no one in his family for generations died from cancer and all lived well into their 90s and some 100s. Nearly all of them die from heart disease or natural causes but not one case of cancer. He had no known risk factors for cancer." And the list goes on and on.

Hundreds of cancer victims and the survivors of those that have died from the disease have hired Zantac cancer lawyers to file a claim for monetary compensation and punitive damages from Sanofi, the maker of Zantac. These stories are typical of individuals that have joined class-action ranitidine lawsuits, multidistrict litigation, or have filed an individual case against Sanofi. For over twenty years, Sanofi earned billions of dollars in profits from selling the world's leading heartburn and acid reflux medicine yet failed to inform the public of what they knew of were expected to have known about the health hazards of their product. The US Food and Drug Administration (FDA) has recalled all ranitidine products from store shelves and it is unknown when or if the product will ever return. Canada Health is requiring companies that are hoping to sell ranitidine to comply with a list of demands such as regularly testing ranitidine products taken from store shelves for NDMA and other contaminates.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.